Thiazole Piperidine Derivatives for P2X7 Antagonism
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is an unmet need for compounds that can efficiently antagonize the P2X7 receptor and be delivered to different target organs, including the brain, where P2X7-mediated pathology occurs.
Innovation Solution
Development of thiazole compounds of a specific formula, including pharmaceutically acceptable salts and stereochemically isomeric forms, which act as P2X7 receptor antagonists, allowing for targeted treatment of various diseases associated with P2X7 receptor activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional P2X7 inhibitors are used, then P2X7 receptor antagonism is achieved, but delivery to target organs including the brain is insufficient
Solution Approach 1:
The patent modifies the chemical parameters of P2X7 inhibitors by introducing specific substituents (halogens, alkyl groups, heteroatoms) at defined positions in the molecular structure. These parameter changes optimize the compounds' pharmacokinetic properties, enabling them to cross the blood-brain barrier and reach target organs effectively while maintaining P2X7 receptor antagonism efficacy
Solution Approach 2:
The invention creates composite molecular structures combining multiple functional groups (thiazole ring, piperidine moiety, substituted benzamide) into a single agent. This composite approach allows the molecule to simultaneously achieve P2X7 receptor binding and appropriate pharmacokinetic properties for delivery to various target organs including the brain
2Adaptability or versatility
If P2X7 receptor antagonists are developed for broad disease treatment, then therapeutic versatility is improved, but compound specificity and selectivity may be compromised
Solution Approach 1:
The patent introduces specific local substitutions at defined positions in the molecular structure (e.g., halogens at positions 2 and 6 of the benzamide ring, specific substituents on the piperidine nitrogen). These localized modifications maintain high specificity for P2X7 receptor binding while the overall molecular framework provides versatility for treating multiple P2X7-mediated diseases
Solution Approach 2:
The molecular structure is segmented into distinct functional domains: the thiazole-5-carboxamide core for receptor binding, the substituted piperidine moiety for pharmacokinetic optimization, and variable substituents that can be tailored for specific disease indications. This segmentation allows independent optimization of specificity and versatility
Data Source
Figure 1
AI summary
The present invention relates to novel substituted phenoxy- and benzyloxy-piperidine compounds of formula (I) having P2X7 receptor (P2X7) antagonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans.